Navigation Links
Duramed's Lo SEASONIQUE(R) NDA Accepted for Filing by FDA
Date:2/25/2008

MONTVALE, N.J., Feb. 25 /PRNewswire-FirstCall/ -- Barr Pharmaceuticals, Inc. (NYSE: BRL) today announced that its subsidiary, Duramed Pharmaceuticals, Inc., has received notification that the U.S. Food and Drug Administration (FDA) has accepted for review its New Drug Application (NDA) for Lo SEASONIQUE(R) (levonorgestrel/ethinyl estradiol tablets 0.10 mg/0.02 mg and ethinyl estradiol tablets 0.01 mg) extended-cycle oral contraceptive. The Company is seeking approval to manufacture and market the Lo SEASONIQUE, the first lower dose, extended-cycle oral contraceptive for the prevention of pregnancy. The Prescription Drug User Fee Action (PDUFA) date for the Lo SEASONIQUE NDA is October 24, 2008.

The clinical data supporting the Lo SEASONIQUE NDA resulted from one large pivotal multi-centered, open label clinical trial which concluded in June 2007. The clinical trial involved over 2,200 female subjects between the ages of 18 and 40 at 56 sites throughout the United States. Subjects were enrolled in the clinical trial for a duration of 12 months.

Under the Lo SEASONIQUE extended-cycle regimen, women take active tablets of 0.10 mg levonorgestrel/0.02 mg of ethinyl estradiol for 84 consecutive days, followed by seven days of 0.01 mg of ethinyl estradiol. The regimen is designed to reduce the number of withdrawal bleeding periods from 13 to four per year. By contrast, the majority of oral contraceptive products currently available in the United States are based on a regimen of 21 treatment days, followed by seven days of placebo.

Important Information About Oral Contraceptives

It is estimated that more than 16 million women currently take oral contraceptives in the United States. Oral contraceptives are not for every
'/>"/>

SOURCE Barr Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Centocor Announces Ustekinumab Biologic License Application Accepted for Filing by FDA
2. New Drug Application for Tolvaptan, Otsukas Investigational Novel Oral Treatment for Worsening Heart Failure and Hyponatremia, Accepted by the U.S. Food and Drug Administration
3. Nitecs IND Application for Clinical Development With Lodotra Accepted by the FDA
4. Neuralstem Shares Accepted for Trading on Amex(R)
5. Attagenes Breakthrough Transcription Factor Profiling Technology to be Described in Nature Methods
6. Addrenex Pharmaceuticals Reaches Milestone with Filing of NDA for First Product, CloniBID, to Treat Hypertension
7. Finkelstein Thompson LLP Announces Filing of Securities Fraud Class Action Against CellCyte Genetics Corporation
8. Oncolytics Biotech Inc. Announces Filing of Phase 1/2 Clinical Trial with REOLYSIN(R)
9. U.S. District Court Decision About Eisais Legal Action Over Aricept ODT(R) ANDA Filing
10. Reliant Pharmaceuticals Announces the Filing of Registration Statement on Form S-1 For an Initial Public Offering
11. FDA Accepts Ranexa(R) sNDA and NDA for Filing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2015)... May 4, 2015 GliaCure, a privately-held ... therapies for neurological and neuropsychiatric disorders based on ... of Alzheimer,s patients in a Phase 1b clinical ... compound developed as a potential disease-modifying treatment. GliaCure,s ... in that it both promotes the clearance of ...
(Date:5/4/2015)... May 4, 2015  RegeneRx Biopharmaceuticals, Inc. (OTCQB: ... an independent team of researchers from ... B4 (TB4) plays an important role in accelerating ... in an experimental mouse model, by promoting blood ... damaged dermal tissue.  The research found that the ...
(Date:5/4/2015)... PHILADELPHIA , May 4, 2015 ... help thousands of med students prepare for the United ... a world-leading provider of scientific, technical and medical information ... a free MOOC (Massive Open Online Course) designed to ... Licensing Examination (USMLE) Step 1, the first and most ...
(Date:5/1/2015)... May 1, 2015  Northwest Biotherapeutics (NASDAQ: NWBO ... personalized immune therapies for solid tumor cancers, announced today ... second tranche of a $40 million investment from Woodford ... first invested $25 million in NW Bio on November ... an agreement with the Company for a further $40 ...
Breaking Biology Technology:GliaCure Initiates Phase 1b Dosing in Alzheimer's Patients 2Researchers Report that Thymosin B4 has a Major Role in Dermal Burn Wound Healing 2Researchers Report that Thymosin B4 has a Major Role in Dermal Burn Wound Healing 3Elsevier's Free MOOC Prepares Med Students for Licensing Exam 2Elsevier's Free MOOC Prepares Med Students for Licensing Exam 3NW Bio Closes On $28.5 Million Second Tranche Of Woodford $40 Million Financing 2NW Bio Closes On $28.5 Million Second Tranche Of Woodford $40 Million Financing 3
... Standard Networks, Inc., a Madison software developer, ... three months of 2006, thanks largely to a 125 ... and message transfer management products. , ,Citing its privately ... for MOVEit, but said Standard Network's overall revenues increased ...
... After a brief hiatus, Steven A. Schmidt ... and chief operating officer, effective April 26. , ,Schmidt, ... January to pursue another opportunity. He had served as ... and operations, and now will succeed founder Terrance D. ...
... Milwaukee, Wis. Hidden factors may contribute as ... projects as the easily identifiable suspects, technology executives were ... Clerestory Consulting in Chicago, delivered that sobering message ... Executives Club seminar on IT governance and project management. ...
Cached Biology Technology:Consultant says beware hidden costs of bad IT projects 2Consultant says beware hidden costs of bad IT projects 3
(Date:3/24/2015)... --Research and Markets ( http://www.researchandmarkets.com/research/hdgz7h/global_iris ) has ... Market 2015-2019" report to their offering. ... grow at a CAGR of 23.5 percent over the ... scenario and the growth prospects of the Global Iris ... market size, the report considers the revenue generated from ...
(Date:3/24/2015)... , March 24, 2015   Crossmatch ™, ... today announced that its U.are.U ® 4500 ... Goorin Bros . to achieve PCI compliance ... secures access to the POS terminal, protecting the ... of data breaches. With one-third ...
(Date:3/23/2015)... , March 23, 2015  In the 2014 ... fraud case conviction losses. This figure accounts for a ... according to The Nilson Report, exceeds $11 billion globally. ... tool after a crime has occurred. Investor Mark ... polygraph expert Joe Paolella partnered to administer ...
Breaking Biology News(10 mins):Global Iris Recognition Market 2015-2019 with 3M Cogent, Bioenable Technologies, Cross Match Technology, Iris ID Systems & Safran Dominating 2Crossmatch Fingerprint Readers Help Retailer Prevent Data Breaches at Point-of-Sale 2Polygraph Test Now Used to Protect Investors From Fraud 2Polygraph Test Now Used to Protect Investors From Fraud 3
... Institute of Medicine (IOM) today announced the names of 70 ... meeting. Election to the IOM is considered one of ... and recognizes individuals who have demonstrated outstanding professional achievement and ... honor to welcome our highly distinguished colleagues to the Institute ...
... where more than 80% of the United States, strawberry ... impact of these vast production systems on groundwater contamination. ... issue of HortScience , changes in growers, cultural ... strawberry yields in the region by 140% during the ...
... Shenzhen, China, October 21, 2013 -- Life Technologies Corporation ... and service provider, jointly announced that BGI has purchased ... least a dozen more by the end of the ... industry. BGI also signed a supply and licensing agreement ...
Cached Biology News:Institute of Medicine Elects 70 New Members, 10 Foreign Associates 2Institute of Medicine Elects 70 New Members, 10 Foreign Associates 3Institute of Medicine Elects 70 New Members, 10 Foreign Associates 4Institute of Medicine Elects 70 New Members, 10 Foreign Associates 5Institute of Medicine Elects 70 New Members, 10 Foreign Associates 6Institute of Medicine Elects 70 New Members, 10 Foreign Associates 7Institute of Medicine Elects 70 New Members, 10 Foreign Associates 8Institute of Medicine Elects 70 New Members, 10 Foreign Associates 9New research informs California strawberry production practices 2BGI partners with Life Technologies to offer sequencing applications on ion torrent 2
... controller is the successor to the original DS-U1. ... of the cameras in the Nikon DS camera ... interface. The DS-U2 transmits information at high speed, ... both hub and mass storage USB 2.0 interfaces. ...
...
... supplied as a 5x solution. Designed ... membrane-bound proteins without destroying antigenic binding ... radioisotopic signals from blots. Not recommended ... as a 5X solution sufficient to ...
... is for fine-tuning the bombardment conditions for ... recommended when you are first using the ... 0.25 g each of 0.6 micrometer, 1.0 ... 100 each of 9 rupture disks, 500 ...
Biology Products: